Obrecht-Sturm D, Schomig L, Mynarek M, Bison B, et al. Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment. Neuro Oncol 2024 Apr 5:noae071. doi: 10.1093.
PMID: 38578306